MentionFox
Home › Layoffs › Mersana Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Mersana Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Mersana Therapeutics, Inc.

MentionFox check on Mersana Therapeutics, Inc.: only 1 source on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/mersana-therapeutics

  • Note: Layoff plan disclosed May 2025 (filing)

New since last check: Layoff plan disclosed May 2025 (filing, first seen 14 November 2026).

Check Mersana Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Mersana Therapeutics, Inc.?

Every exit or restructuring plan Mersana Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

Mersana Therapeutics, Inc.'s latest layoff filing, on May 6, 2025, states a cut of about 55% of its workforce. As of November 15, 2026, it has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05. No WARN notice under its name is on file in the states covered here (Form 8-K, May 6, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Bain Capital Life Sciences Fund II, L.P. also filed stake reports on 2 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Mersana Therapeutics, Inc.

Free to see. No signup.

People from Mersana Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Mersana Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest filing2025-05-06

Mersana Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Mersana Therapeutics have layoffs in 2025? What its filings say

Mersana Therapeutics, Inc. (CIK 1442836) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-05-06

Share of workforce

In connection therewith, on May 5, 2025, the Company's board of directors approved certain expense reduction measures, including the Company's commitment to a reduction of approximately 55% of the Company's current employee base across all functions (the "Restructuring").

Expected charges

As a result of the Restructuring, the Company estimates that it will incur approximately $4-5 million in costs resulting from cash expenditures consisting of severance and benefit payments, outplacement services and related expenses.

Timing

The Restructuring is expected to be substantially complete by the end of the third quarter of 2025.

Also on the record for Mersana Therapeutics, Inc.

DateRecordFigureOur pageSource
May 15, 2026Stake report, Schedule 13G/A, by 683 Capital Management, LLC—5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by 683 Capital Management, LLC7.03% of the class5%+ stakesSource
February 17, 2026Stake report, Schedule 13G/A, by Schonfeld Strategic Advisors LLC—5%+ stakesSource
January 30, 2026Stake report, Schedule 13G/A, by The Vanguard Group4.2% of the class5%+ stakesSource
January 9, 2026Stake report, Schedule 13G/A, by Nextech Crossover I GP S.a. r.l.—5%+ stakesSource
January 8, 2026Stake report, Schedule 13D/A, by Bain Capital Life Sciences Fund II, L.P.—5%+ stakesSource
January 6, 2026Acquired by Day One Biopharmaceuticals, Inc.—AcquisitionSource
January 6, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
November 24, 2025Stake report, Schedule 13G, by 683 Capital Management, LLC5.47% of the class5%+ stakesSource
November 14, 2025Stake report, Schedule 13G, by Schonfeld Strategic Advisors LLC5.48% of the class5%+ stakesSource
November 13, 2025Stake report, Schedule 13D/A, by Bain Capital Life Sciences Fund II, L.P.4% of the class5%+ stakesSource
August 14, 2025Stake report, Schedule 13G/A, by Schonfeld Strategic Advisors LLC4.55% of the class5%+ stakesSource

Keep reading

More on Mersana Therapeutics, Inc. and the records around it.

Mersana Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Mersana Therapeutics, Inc.?

Want the whole picture on Mersana Therapeutics, Inc.?

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Mersana Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Mersana Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    12 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 13 records.

Tools for this story

Each opens in a new tab, filled in for Mersana Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/mersana-therapeutics
Last updated 2026-11-15
Mersana Therapeutics layoffs 2025: 55% of workforce (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/mersana-therapeutics